GUBRF Intrinsic Valuation and Fundamental Analysis - Gubra A/S

Intrinsic Value

The intrinsic value of Gubra A/S (GUBRF) under the Base Case is 49.44 USD per share. Compared with the current market price of 60.15 USD, the stock appears Overvalued by 18% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

GUBRF Intrinsic Value

Overvaluation 18%

Intrinsic Value

Price $60.15

G

Track Buy Zone

20% below Intrinsic Value $39.55

Get notified when the price drops into your buy zone

Current Price $60.15

Intrinsic Value $49.44

Margin of Safety 20% $39.55

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Gubra A/S Does

Life Sciences Tools & Services Health Care

Gubra A/S is a Danish biotechnology company with two main businesses: it helps drug makers discover and test new medicines, and it develops its own peptide-based drug candidates. In its service business, Gubra works as a research partner for pharmaceutical and biotech companies, especially on metabolism, obesity, diabetes, and related disease areas. In its own pipeline, it focuses on finding and advancing treatments built around biologically active peptides.

Headquarters: Denmark DK
Employees: 300
IPO date: Apr 4, 2023